NEWS 26 JUNE 2018

• New NDA approvals (USA)

1. Plazomicin Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infection.
2. GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of cannabidiol oral solution – the FirstPlant-derived Cannabinoid Prescription Medicine.

• New ANDA Approvals (USA)

1. US FDA approves Aurobindo Pharma's generic Ertapenem Injection.

*For browsing official press releases click on the respective news item.